封面
市場調查報告書
商品編碼
1198192

遠程病人監護系統市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)

Remote Patient Monitoring Systems Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在預測期內,遠程患者監護系統市場的複合年增長率為 8.54%。

COVID-19 大流行給全球人手不足和工作過度的醫院和醫療保健系統帶來了巨大壓力。 遠程患者監控技術對市場產生了積極影響,它允許患者在家中保持安全,同時減輕大流行期間醫院、急診室和一線醫護人員的壓力。 USFDA 頒布了新法規,允許醫療保健專業人員使用 FDA 批准的遠程患者監測 (RPM) 設備來評估患者的體溫、呼吸頻率、心率和血壓,而無需進行侵入性操作。 COVID-19 為臨床醫生和患者有效使用 RPM 奠定了堅實的基礎。 根據 Jordan D. Coffey 在 NPJ Digital Medicine 上發表的 2021 年報告,RPM 技術在整個大流行期間的參與率為 78.9%。 大流行期間 RPM 設備的高利用率對所研究的市場產生了積極影響。 目前,市場對 RPM 設備的需求已達到大流行前的狀態。 然而,預計未來幾年將出現強勁增長。

推動市場發展的主要因素包括生活方式改變導致慢性病負擔增加、人口迅速老齡化以及對家庭監控設備的需求不斷增加。 遠程患者監控是門診醫療保健,患者使用移動醫療設備執行常規測試並將測試數據實時發送給醫療專業人員。

從全球角度來看,不斷增加的慢性病人口、老齡化人口以及對家庭監控設備的需求正在推動市場增長。 例如,根據美國癌症協會2022年發布的年度報告,美國癌症新發病例數將達到190萬左右,預計將有超過50萬人死於癌症。 這種高癌症發病率和高死亡率可能會導致更多地使用監測設備來了解受影響個體的健康狀況。 因此,由於癌症等慢性病的增加,預計該市場將出現顯著增長。

這些設備還小巧便攜,讓患者可以全天佩戴而不會感到不適。 這些設備還確保持續監測患者的狀況。 對家庭監控設備的需求不斷增長也推動了市場增長。 根據 2021 年醫療保險和醫療補助服務中心的數據,遠程監控器已幫助多名高危患者避免再次入院,並在家中過上更健康的生活。 使用遠程監控的客戶報告說再入院率降低了 76%,平均患者滿意度為 89%,並節省了大約 3.7 億美元的總醫療費用。

但是,醫療保健行業專業人士對引入監控系統的抵制、新興市場對適當報銷政策的需求以及嚴格的監管框架正在阻礙市場增長。

遠程病人監護系統市場趨勢

多參數監護儀領域有望在預測期內實現強勁增長

多參數監護儀是一種監測各種參數的設備,例如動脈血壓、心率、體溫/皮膚溫度、血氧飽和度和二氧化碳圖。 這些設備很受歡迎,因為它們體積小、便攜且易於使用。 這些多參數遠程監護設備被醫療專業人員和注重健康的個人使用,睡眠監測器和活動監測器也屬於這些類別。 在發達國家和美國等新興國家,慢性病死亡率不斷上升,這提高了患者群體選擇可以及早輕鬆監測的設備的意識。

市場參與者採取了各種策略,包括產品發布、產品開發、合作夥伴關係和擴張,以增加他們的市場份額。 例如,2022 年 4 月,新加坡品牌 BUZUD 復星商貿醫療推出了 BUZUD 多參數監護儀 (MPM),旨在簡化醫療監控流程並幫助醫療保健專業人員為患者提供更高水平的護理。並推出兩款新的醫療設備,BUZUD PulseBit EX,一種價格適中且方便的心電圖 (ECG) 個人追蹤器,適用於心髒病患者。 此類產品的推出有望推動該細分市場的增長。

因此,人們越來越關注健康的生活方式,越來越關注對患者健康參數的持續監測,自我監測和預防醫學的上升趨勢預計將推動整個細分市場的增長。.

北美有望在預測期內對市場做出重大貢獻

推動市場增長的主要因素包括慢性病負擔加重、人口老齡化加劇、對無線和便攜式系統的需求以及復雜的醫療報銷系統。

新產品的推出是對北美地區市場增長做出重大貢獻的主要因素。 例如,2022 年 5 月,Novant Health 與 Health Recovery Solutions 合作推出遠程患者監護系統。 該合作夥伴關係將從一個針對肥胖患者的試點項目開始,併計劃在未來幾年內擴展到其他患者群體。

此外,該國的市場參與者已採取各種策略,例如產品發布、產品開發、合作夥伴關係和擴張,以增加其市場份額。 例如,2022 年 10 月,領先的最後一英裡移動醫療服務提供商 DocGo 將在其與 Gary 和 Mary West PACE 的現有合作夥伴關係的基礎上,在美國推出突破性的遠程患者監護 (RPM) 解決方案。 2022年7月,瑞士醫療科技公司Sleepiz在美國食品藥品監督管理局(FDA)註冊了非接觸式呼吸心率監測設備“Sleepiz One+”。 FDA 註冊為 Sleepiz 在美國提供遠程患者監測和臨床試驗解決方案鋪平了道路。

因此,由於上述因素,預計北美地區將在預測期內實現增長。

遠程病人監護系統市場競爭對手分析

遠程患者監護系統市場較為分散。 市場上有各種醫療設備製造商和幾家專業的遠程病人監護設備製造商。 該行業競爭激烈,行業參與者和其他醫療設備製造商正在積極尋求合作夥伴關係和協議,以整合遠程患者監控功能。 主要市場參與者包括 Abbott Laboratories、Aerotel Medical Systems、AMD Global Telemedicine、Baxter International Inc.、Boston Scientific Corporation、GE Healthcare、Masimo Corporation、Medtronic PLC、F. Hoffmann-La Roche AG、Omron Corporation 等。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 生活方式的改變和老年人口的增加導致慢性病負擔增加
    • 對家庭監控設備的需求不斷擴大
    • 遠程患者監護 (RPM) 設備的技術進步
  • 市場製約因素
    • 來自醫療保健行業專業人士的抵制
    • 嚴格的監管框架
    • 缺乏適當的報銷
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按設備類型
    • 心臟監測器
    • 呼吸監測器
    • 血細胞計數器
    • 多參數監護儀
    • 其他
  • 通過申請
    • 癌症治療
    • 心血管疾病
    • 糖尿病治療
    • 睡眠障礙
    • 體重管理和健身監測
    • 其他應用
  • 最終用戶
    • 家庭護理
    • 醫院/診所
    • 其他最終用戶
  • 區域信息
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Abbott Laboratories
    • Aerotel Medical Systems
    • AMD Global Telemedicine
    • Baxter International Inc.
    • Boston Scientific Corporation
    • GE Healthcare
    • Masimo Corporation
    • Medtronic PLC
    • Omron Corporation
    • Philips Healthcare
    • OSI Systems Inc.
    • Dragerwerk AG & Co. KGaA
    • Compumedics Limited
    • Nihon Kohden Corporation
    • F. Hoffmann-La Roche AG

第七章市場機會與未來趨勢

簡介目錄
Product Code: 56857

The remote patient monitoring systems market is expected to register a CAGR of 8.54% during the forecast period.

The COVID-19 pandemic placed enormous pressure on hospitals and healthcare systems that were understaffed and overworked globally. Remote patient monitoring technology helped patients remain safe within their homes while reducing stress on hospitals, emergency rooms, and front-line healthcare workers during the pandemic, thereby positively impacting the market. The USFDA established a new regulation allowing healthcare practitioners to use FDA-approved Remote Patient Monitoring (RPM) devices to assess patients' body temperature, respiration rate, heart rate, and blood pressure without invasive procedures. COVID-19 has provided a strong foundation for clinicians and patients to use RPM effectively. According to a report published in NPJ Digital Medicine in 2021 by Jordan D. Coffey, the RPM technology engagement rate was 78.9% throughout the pandemic. The market studied was positively impacted by the high utilization of RPM devices during the pandemic. Currently, the market has reached a pre-pandemic status in terms of demand for RPM devices. However, it is expected to witness strong growth in the coming years.

The major factors driving the market include the rising burden of chronic diseases due to lifestyle changes, the surge in the geriatric population, and the growing demand for home-based monitoring devices. Remote patient monitoring is ambulatory healthcare that allows patients to use a mobile medical device to accomplish a routine test and guide the test data to a healthcare expert in real time.

Globally, the rising chronic disease population, the increasing aging population, and the demand for home-based monitoring devices are boosting the market's growth. For instance, according to the American Cancer Society's annual report published in 2022, an estimated number of new cancer cases in the United States was believed to reach around 1.9 million, and over half a million people were expected to die due to cancer in the country. Owing to the high expected incidence of cancer and the high mortality, there will be growing use of monitoring devices to track health among the affected population. Hence, the market studied will be witnessing a strong growth due to the rising chronic diseases such as cancer.​

In addition, these devices are compact and portable, and patients can wear them all day without feeling uneasy. These devices also ensure that the patient's condition is monitored continuously. Growing demand for home-based monitoring devices also boosts the market's growth. According to the Center for Medicare and Medicaid Services in 2021, remote monitors help several high-risk patients avoid being readmitted to the hospital and make the most of their healthy days at home. Clients who use remote monitoring report a 76% reduction in readmission rates, an average of 89% patient satisfaction, and a total medical cost savings of nearly USD 370 million.

However, healthcare industry professionals' resistance to adopting monitoring systems, a need for proper reimbursement policies in developed markets, and the stringent regulatory framework impede the market's growth.

Remote Patient Monitoring Systems Market Trends

The Multi-parameter Monitors Segment is Expected to Register Significant Growth over the Forecast Period

Multi-parameter monitors are devices with a single device that monitors various parameters, such as arterial blood pressure, heart rate, body and skin temperature, oximetry, and capnography. These devices have become popular as they are small, portable, and user-friendly. These multi-parameter remote monitoring devices are used by medical professionals and the health-conscious population, as sleep and activity monitors fall into these categories. The increased death rate due to chronic diseases across developed countries, such as the United States, and developing countries, has raised awareness among the patient population to opt for early and easy-to-monitor devices.

The market players adopted various strategies, such as product launches, product developments, collaborations, and expansions, to increase their market share. For instance, in April 2022, Singapore brand BUZUD, Fosun Trade Medical Device, launched two new medical devices, namely the BUZUD Multi-Parameter Monitor (MPM), designed to streamline the medical monitoring process and help healthcare professionals provide a higher level of care to their patients, and the BUZUD PulseBit EX, a personal electrocardiogram (ECG) tracker that makes heart care affordable and convenient for heart patients. Such launches are expected to propel the growth of the market segment.

Therefore, the rising focus on a healthy lifestyle, increasing concerns about the constant monitoring of patients' health parameters, and the growing trend of self-monitoring and preventive medicine are expected to drive the growth of the overall market segment.

North America is Expected to be the Major Contributor to the Market over the Forecast Period

The major factors driving the market's growth include the growing burden of chronic diseases, an increasing geriatric population, demand for wireless and portable systems, and a sophisticated reimbursement structure.

New product launches are a major factor contributing significantly to the market growth in the North American region. For instance, in May 2022, Novant Health launched a remote patient monitoring system in partnership with Health Recovery Solutions. The partnership was launched with a pilot program focused on bariatric patients, with plans to expand to other patient populations in the coming years.

Furthermore, the market players in the country adopted various strategies such as product launches, product developments, collaborations, and expansions to increase their market share. For instance, in October 2022, DocGo, a leading provider of last-mile mobile health services, announced that it would build upon its existing partnership with Gary and Mary West PACE and introduce a revolutionary remote patient monitoring (RPM) solution in the United States. In addition, in July 2022, Switzerland-based medical technology company Sleepiz registered its Sleepiz One+ contactless respiration and heart rate measuring device with the United States Food and Drug Administration (FDA). The FDA listing paved the way for Sleepiz to offer its solution for remote patient monitoring and clinical trials in the United States.

Therefore, the North American region is expected to register growth over the forecast period due to the abovementioned factors.

Remote Patient Monitoring Systems Market Competitor Analysis

The remote patient monitoring systems market is moderately fragmented. Various medical device manufacturers and several specialized remote patient monitoring equipment manufacturers are operating in the market. The industry is highly competitive, and there is a growing trend of partnerships and agreements between industry participants and other medical device manufacturers to incorporate remote patient monitoring functionalities. Some key market players include Abbott Laboratories, Aerotel Medical Systems, AMD Global Telemedicine, Baxter International Inc., Boston Scientific Corporation, GE Healthcare, Masimo Corporation, Medtronic PLC, F. Hoffmann-La Roche AG, and Omron Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Diseases Due to Lifestyle Changes and Increasing Geriatric Population
    • 4.2.2 Growing Demand for Home-based Monitoring Devices
    • 4.2.3 Technological Advancements in Remote Patient Monitoring (RPM) Devices
  • 4.3 Market Restraints
    • 4.3.1 Resistance from Healthcare Industry Professionals
    • 4.3.2 Stringent Regulatory Framework
    • 4.3.3 Lack of Proper Reimbursement
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type of Device
    • 5.1.1 Heart Monitors
    • 5.1.2 Breath Monitors
    • 5.1.3 Hematology Monitors
    • 5.1.4 Multi-parameter Monitors
    • 5.1.5 Other Types of Devices
  • 5.2 By Application
    • 5.2.1 Cancer Treatment
    • 5.2.2 Cardiovascular Diseases
    • 5.2.3 Diabetes Treatment
    • 5.2.4 Sleep Disorder
    • 5.2.5 Weight Management and Fitness Monitoring
    • 5.2.6 Other Applications
  • 5.3 By End-User
    • 5.3.1 Home Care Settings
    • 5.3.2 Hospitals/Clinics
    • 5.3.3 Other End-Users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Aerotel Medical Systems
    • 6.1.3 AMD Global Telemedicine
    • 6.1.4 Baxter International Inc.
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 GE Healthcare
    • 6.1.7 Masimo Corporation
    • 6.1.8 Medtronic PLC
    • 6.1.9 Omron Corporation
    • 6.1.10 Philips Healthcare
    • 6.1.11 OSI Systems Inc.
    • 6.1.12 Dragerwerk AG & Co. KGaA
    • 6.1.13 Compumedics Limited
    • 6.1.14 Nihon Kohden Corporation
    • 6.1.15 F. Hoffmann-La Roche AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS